Skip to content

Clinical trials

Completed Phase 2 Coronary Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 2 Status: Completed Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20021
20043
20053
20064
20072
20084
20101
20115
20123
20132
20142
20162
20172
20203
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)12
Hoffmann-La Roche5
National Center for Complementary and Integrative Health (NCCIH)2
Novartis Pharmaceuticals2
Sanofi2
ARCA Biopharma, Inc.1
Abbott Medical Devices1
AstraZeneca1
Baystate Medical Center1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease60
Myocardial Ischemia16
Coronary Artery Disease15
Heart Diseases13
Cardiovascular Diseases11
Myocardial Infarction7
Atherosclerosis6
Acute Coronary Syndrome4
Vascular Diseases4
Arterial Occlusive Diseases3

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.